ホーム › 尿路上皮（移行上皮）癌 › ペンシルベニア
ペンシルベニアにおける尿路上皮（移行上皮）癌の臨床試験
ペンシルベニア内の拠点で、尿路上皮（移行上皮）癌に関する15件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #104, Hershey
- Exelixis Clinical Site #98, Philadelphia
- Exelixis Clinical Site #32, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- UPMC Hillman Cancer Center Erie, Erie
- 他22件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06524544Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- 他8件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- UPMC Hillman Cancer Center ( Site 1014), Pittsburgh
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05562830A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
- AHN Allegheny General Hospital, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital at Broad Street, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07043972A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Penn State Milton S Hershey Medical Center, Hershey
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06774131Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
- Fox Chase Cancer Center, Philadelphia
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06966024Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer
- Fox Chase Cancer Center, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/16更新 · NCT06356155Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Penn State Medical Center, Urology Research, Hershey
被験者募集中
18歳〜88歳 · 全性別 · 2026/07/02更新 · NCT06394869Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
- Fox Chase Cancer Center - Philadelphia, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/19更新 · NCT07221942Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
被験者募集中
18歳〜85歳 · 全性別 · 2026/02/17更新 · NCT07234968Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
- Fox Chase Cancer Center, Philadelphia
被験者募集中観察研究
18歳以上 · 全性別 · 2025/10/31更新 · NCT06396533SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。